Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 836 of 1,261

  1. US 8617815

    Molecules with effects on cellular development and function

    The Regents of the University of California · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  2. US 8617600

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  3. US 8618095

    2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses

    Rigel Pharmaceuticals, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  4. US 8618080

    Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines

    OM PHARMA · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  5. US 8618110

    Compositions and methods for apoptosis modulators

    VM Discovery Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  6. US 8618096

    Prodrug compositions and methods for using the same in treating cancer and malaria

    The Regents of the University of California · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  7. US 8618074

    GPCR enhanced neuroprotection to treat brain injury

    The Board of Regents of the University of Texas System · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  8. US 8618331

    Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  9. US 8618090

    Inhibitors of the plasmodial surface anion channel as antimalarials

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  10. US 8617132

    Bioresorbable embolization microspheres

    Regents of the University of Minnesota · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  11. US 8617532

    Therapeutic use of interferon-polymer conjugates

    PHARMAESSENTIA CORPORATION · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  12. US 8617538

    Mesodermal-like cell population for treating ischemia in mammals

    The Board of Regents of the University of Texas System · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  13. US 8616429

    Structure containing wound treatment material

    Covidien LP · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  14. US 8617549

    Bispecific nanobodies as a therapeutic for alzheimer's disease

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  15. US 8618134

    Method and composition for treating a serotonin receptor-mediated condition

    VANDA PHARMACEUTICALS INC. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  16. US 8618142

    Process for the preparation of roflumilast

    TAKEDA GMBH · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  17. US 8618167

    Methods of attenuating cognitive deficits with sulfonyl fluorides

    The Board of Regents of the University of Texas System · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  18. US 8618324

    Composition and method for making oligo-benzamide compounds

    The Board of Regents of the University of Texas System · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  19. US 8618270

    Oligonucleotide analog and method for treating flavivirus infections

    Sarepta Therapeutics, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  20. US 8618259

    Polymer-factor VIII conjugate compositions

    Nektar Therapeutics · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  21. US 8613932

    GP100-specific T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  22. US 8613905

    Diagnostic agent

    UNITED ARAB EMIRATES UNIVERSITY · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  23. US 8613934

    Cellular and viral inactivation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

  24. US 8614208

    Fused heterocyclic ring derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.